Karen Wood
Obstetrics & Gynecology · Reno, NVNPI 1265561740
Payments from drug & device makers
Across 73 payments — averaging $18.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$418
- AbbVie$297
- Urovant Sciences Inc$115
- Mayne Pharma Commercial LLC$88
- Bayer$80
- Bausch Health US, LLC$74
- plus $298 from 11 others
What the payments were for
- Food & beverage$1,370100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 20 | $418 |
| AbbVie | 20 | $297 |
| Urovant Sciences Inc | 4 | $115 |
| Mayne Pharma Commercial LLC | 7 | $88 |
| Bayer | 4 | $80 |
| Bausch Health US, LLC | 4 | $74 |
| Scynexis, Inc. | 2 | $60 |
| Myovant Sciences Inc. | 2 | $35 |
| Agile Therapeutics, Inc. | 2 | $33 |
| Coloplast | 1 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Dysis Medical, Inc. | 1 | $19 |
| Evofem Biosciences, Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Merck | 1 | $14 |
How this compares
$1,370 in reported general payments places this provider in the 55th percentile of 308 obstetrics & gynecology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremproEstrogen,con/M-Progest Acet | 14 | $5,098 |
| Estradiol | 74 | $4,336 |
| ProgesteroneProgesterone, Micronized | 13 | $322 |
| Fluconazole | 13 | $86 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Reno
- Arathi VeeraswamyReno$23K
- Maria TorresReno$12K
- Lindsay BridgewaterReno$11K
- Rafaela HernandezReno$4K
- Sarah McKenzieReno$4K
- Bruce FarringerReno$4K
- Liliana Ruiz-LeonLas Vegas$4.6M
- Rex MabeyLas Vegas$2.2M
- Edmond PackLas Vegas$1.5M
- Darin SwainstonLas Vegas$713K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.